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Abstract
Maximal neuromuscular power is an important determinant of athletic perfor-
mance and also quality of life, independence, and perhaps even mortality in
patient populations. We have shown that dietary nitrate (NO3
), a source of
nitric oxide (NO), improves muscle power in some, but not all, subjects. The
present investigation was designed to identify factors contributing to this
interindividual variability. Healthy men (n = 13) and women (n = 7) 22–
79 year of age and weighing 52.1–114.9 kg were studied using a randomized,
double-blind, placebo-controlled, crossover design. Subjects were tested 2 h
after ingesting beetroot juice (BRJ) either containing or devoid of
12.3  0.8 mmol of NO3. Plasma NO3 and nitrite (NO2) were measured
as indicators of NO bioavailability and maximal knee extensor speed (Vmax),
power (Pmax), and fatigability were determined via isokinetic dynamometry.
On average, dietary NO3
 increased (P < 0.05) Pmax by 4.4  8.1%. Individ-
ual changes, however, ranged from 9.6 to +26.8%. This interindividual vari-
ability was not significantly correlated with age, body mass (inverse of NO3

dose per kg), body mass index (surrogate for body composition) or placebo
trial Vmax or fatigue index (in vivo indicators of muscle fiber type distribu-
tion). In contrast, the relative increase in Pmax was significantly correlated
(r = 0.60; P < 0.01) with the relative increase in plasma NO2
 concentration.
In multivariable analysis female sex also tended (P = 0.08) to be associated
with a greater increase in Pmax. We conclude that the magnitude of the diet-
ary NO3
-induced increase in muscle power is dependent upon the magni-
tude of the resulting increase in plasma NO2
 and possibly female sex.
Introduction
Maximal neuromuscular power is an important determi-
nant of athletic performance and is also highly significant
from a clinical perspective, as reductions in power con-
tribute to impaired quality of life, disability, and possibly
even mortality in various patient populations (e.g., the
elderly (Guralnik et al. 1994), heart failure (HF) patients
(H€ulsmann et al. 2004)). It is therefore noteworthy that
recent studies have demonstrated that acute or chronic
supplementation with dietary nitrate (NO3
), a source
of nitric oxide (NO) via the enterosalivary pathway
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(Lundberg and Weitzberg 2009), can influence muscle con-
tractile properties (Haider and Folland 2014; Coggan et al.
2015a,b; Justice et al. 2015; Rimer et al. 2016; Whitfield
et al. 2017). In a previous study, for example, we found that
acute ingestion of NO3
 increased maximal knee extensor
speed and power in healthy, untrained individuals by 11
and 6%, respectively, (Coggan et al. 2015b). We observed a
similar dietary NO3
-induced enhancement of maximal
neuromuscular power in athletes (Rimer et al. 2016), and
an even greater increase (i.e., 13%) in patients with HF
(Coggan et al. 2015a). NO3
 (or nitrite (NO2
)) -induced
improvements in muscle contractility have also been
observed in some (Haider and Folland 2014; Justice et al.
2015; Whitfield et al. 2017), albeit not all (Hoon et al.
2015), recent studies of voluntary or electrically stimulated
isometric exercise.
Based on these previous studies (Haider and Folland
2014; Coggan et al. 2015a,b; Justice et al. 2015; Rimer et al.
2016; Whitfield et al. 2017), it therefore appears that diet-
ary NO3
 can enhance the inherent contractile properties
of human muscle. However, as with NO3
-induced
improvements in endurance performance (Christensen
et al. 2013; Boorsma et al. 2014) (or reductions in blood
pressure (Kapil et al. 2010)), not all individuals seem to
respond equally. Specifically, only about three-fourths of
the subjects we have studied previously have demonstrated
improvements in muscle speed and/or power with NO3

intake. The reason for this variability between individuals
is not clear, but it may be related to the extent to which
NO3
 intake increases NO bioavailability. This hypothesis
is suggested by the key role played by oral bacteria in
reducing ingested NO3
 to NO2
, the immediate precursor
for NO synthesis via the enterosalivary pathway (Lundberg
and Weitzberg 2009). Alternatively and/or in addition,
based in part on animal studies it has been proposed that
the effects of dietary NO3
 supplementation are greatest in
type II, or fast-twitch, muscle fibers (Jones et al. 2016). The
interindividual variability in muscle power improvements
that we have observed therefore may be related to differ-
ences in muscle fiber type distribution.
The purpose of this study was to test the hypothesis that
interindividual differences in the effects of dietary NO3
 on
muscle function are related to interindividual differences in
NO production and/or in the percentage of fast-twitch
muscle fibers. To do so, we determined the relationship
between changes in muscle power due to NO3
 ingestion
and markers of NO bioavailability (i.e., plasma NO3
 and
NO2
 levels) and muscle fiber type (i.e., maximal knee
extensor velocity (Vmax) and fatigability in the absence of
NO3
 intake) in a heterogeneous group of healthy men
and women. We recruited subjects widely varying in other
characteristics (e.g., age) as well, to determine whether
there was any relationship between such factors and the
response to dietary NO3
. The results of this study provide
insight into the mechanisms responsible for interindividual
differences in the effects of NO2
 supplementation on
muscle power, which may prove useful in optimizing this
intervention in both athletes and clinical populations.
Methods
Subjects
We studied 13 men and 7 women ranging in age from 22
to 79 (mean 47  20) years, in body mass from 52.1 to
114.9 (mean 78.2  16.3) kg, and in body mass index
(BMI) from 19.1 to 32.6 (mean 25.8  4.2) kg/m2. All of
the subjects were healthy, based upon medical history,
physical examination, and standard blood chemistries.
Although all were normally active, only two exercised reg-
ularly, and none were engaged in training for competitive
sports. None of the subjects smoked. Additional exclusion
criteria included use of drugs that can block reduction of
NO3
 and NO2
 to NO (i.e., prescription sex hormones,
antacids, proton pump inhibitors, or xanthine oxidase
inhibitors) (Lundberg et al. 1994; Obach et al. 2004) or
can potentiate the effects of the latter (i.e., phosphodi-
esterase inhibitors) (Webb et al. 1999). Women who were
pregnant or lactating were also excluded. Approval for
the study was obtained from the Human Subjects Office
at Indiana University and the Human Research Protection
Office at Washington University School of Medicine, and
all subjects provided written, informed consent. Partial
data from some of these subjects has been presented pre-
viously (Coggan et al. 2015b).
Experimental design and protocol
Each subject was studied twice using a double-blind, pla-
cebo-controlled, randomized design. During one trial, sub-
jects were tested after ingesting 140 mL of a commercial
beetroot juice (BRJ) supplement (Beet It, James White
Drinks, Ipswich, UK) containing 12.3  0.8 mmol of
NO3
. During the other trial, they ingested an equal volume
of concentrated BRJ from which the NO3
 had been
removed by the manufacturer. A washout period of
1–2 weeks separated the two trials (i.e., NO3
 vs. placebo).
Since use of an antibacterial mouthwash, tooth brushing, or
chewing gum can block the conversion of NO3
 to NO2
 by
oral bacteria (Lundberg et al. 1994; Govoni et al. 2008), sub-
jects were instructed to avoid these behaviors on study days.
They were also instructed to avoid high NO3
 foods
throughout the study, with adherence to this instruction
verified by analysis of food records by a dietician.
Subjects arrived at the Clinical Research Unit in the
morning after avoiding food, caffeine, or alcohol intake
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for the previous 12 h. A catheter was first inserted in an
antecubital vein and a blood sample obtained for subse-
quent measurement of plasma NO3
 and NO2
 concen-
trations via high-performance liquid chromatography
(ENO-30, Eicom USA, San Diego, CA). These measure-
ments were repeated and 2 h of quiet rest, after which
the contractile properties of the knee extensor muscles of
the subject’s dominant leg were determined using an
isokinetic dynamometer (Biodex System 4 Pro, Biodex
Medical Systems, Shirley, NY) as previously described
(Coggan et al. 2015a,b). Briefly, each subject performed
3–4 maximal knee extensions at angular velocities of 0,
1.57, 3.14, 4.71, and 6.28 rad/sec, with 2 min of rest
between each set. The resulting torque data were filtered
and smoothed to eliminate artifacts, after which peak
power was calculated by multiplying the peak torque
observed at each velocity by that velocity. The power-
velocity data were then fit with a parabolic function to
determine the subject’s Vmax and maximal power (Pmax).
After an additional 2 min of rest, the subject performed
50 consecutive maximal knee extensions at an angular
velocity of 3.14 rad/sec to determine their resistance to
fatigue (i.e., fatigue index, =% decrease in power from
first 1/3 to last 1/3 of the test) during repeated muscle
contractions. Following a 10 min rest period, the final
plasma samples were obtained after which the subject was
fed a light meal and released.
Data analysis
Statistical analyses were performed using GraphPad Prism
version 7.02 (GraphPad Software, La Jolla, CA). Normal-
ity of data distribution was first tested using the D’-
tino-Pearson omnibus test. Data from the placebo and
NO3
 trials were subsequently compared using two-way
(treatment x order) ANOVA, with subject as a repeated
measures factor within treatment. Intraclass correlation
coefficients were calculated from the ANOVA results to
quantify the reliability of the data. Standard Pearson pro-
duct correlations were calculated to explore the
relationship between relative changes in Pmax as the
dependent variable and sex, age, body mass (inverse to
NO3
 dose in lmol/kg), BMI, placebo trial Vmax, placebo
trial fatigue index (in vivo indicators of muscle fiber type
distribution), percent change in plasma NO3
, or percent
change in plasma NO2
 as independent variables. The
overall false discovery rate was limited to 10% using the
Benjamini–Hochberg procedure. As this was an explora-
tory study, stepwise forward regression was also employed
using the same dependent and independent variables,
with the P value to enter the model similarly set to 0.10.
Results
The effects of ingesting BRJ without or with NO3
 on
plasma NO3
 and NO2
 concentrations are shown in
Table 1. No significant changes occurred in the placebo
trial, whereas during the NO3
 trial, both NO3
 and
NO2
 increased significantly. This was accompanied by a
significant (P < 0.05) elevation in Vmax, which increased
from 12.3  2.5 (range: 9.3–20.2) rad/sec in the placebo
trial to 13.2  3.1 (range: 8.4–20.2) rad/sec in the NO3
trial. Pmax also increased significantly (P < 0.05), that is,
from 6.3  2.3 (range: 2.8–10.7) to 6.6  2.4 (range:
2.7–11.8) W/kg. Individual changes varied from 9.6 to
+26. % (Fig. 1). On the other hand, the fatigue index was
unaltered by NO3
 intake, averaging 61  13 (range:
34–78) and 61.6  13.5 (range: 32–78)% during the pla-
cebo and NO3
 trials, respectively. All three performance
measures were highly reliable, with intraclass correlation
coefficients of 0.94, 0.98, and 0.89 for Vmax, Pmax, and
fatigue index, respectively. No adverse effects were
observed. These observations confirm and extend our pre-
vious findings (Coggan et al. 2015a,b; Rimer et al. 2016).
The remainder of our effort therefore focused upon
attempting to elucidate the factors responsible for the
marked variability between subjects in the response to
NO3
 intake.
In univariable analyses, the relative increase (i.e., D%)
in Pmax due to dietary NO3
 ingestion was not
Table 1. Changes in plasma NO3
 and NO2
 in response to NO3

Time point
Trial Pre 1 h 2 h 10 min post
Plasma NO3
 (lmol/L) Placebo 26  11 23  9 22  7 23  11
Nitrate 30  18 334  111† 351  74† 346  91†
Plasma NO2
 (lmol/L) Placebo 0.29  0.22 0.30  0.26 0.30  0.28 0.29  0.36
Nitrate 0.36  0.40 0.44  0.33* 0.47  0.34† 0.57  0.32†
Values are mean  SD for n = 19.
Nitrate trial significantly higher than Placebo trial at same time point: *P < 0.01, †P < 0.0001.
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significantly correlated with sex, age, body mass, or BMI,
or with placebo trial Vmax or fatigue index (Table 2).
The relative magnitude of the increase in Pmax was also
not correlated with the relative change in plasma NO3

concentration (Table 2). There was, however, a significant
correlation between the relative increase in Pmax and the
relative increase in plasma NO2
 concentration due to
NO3
 intake (Table 2; Fig. 2). The relative change in
plasma NO2
 concentration was also the strongest predic-
tor of relative changes in Pmax in the multivariable analy-
sis (Table 3). Female sex also tended to be a positive
predictor of relative increases in Pmax in the multivari-
able analysis (Table 3). In keeping with this, female sub-
jects tended (i.e., P = 0.06 by Fisher’s exact test) to be
more likely to exhibit a greater-than-average increase in
Pmax, that is, to be “high responders” (Fig. 2). Taken
together, the relative change in plasma NO2
 concentra-
tion and subject sex explained ~40% of the interindivid-
ual variation in the effect of NO3
 intake on muscle
power (i.e., R2 of multivariable regression = 0.38).
Discussion
The purpose of this study was to identify (if possible) fac-
tors contributing to interindividual variability in improve-
ments in muscle contractile function resulting from
dietary NO3
 intake. Based on previous research, we
hypothesized that such differences would be related to
differences between individuals in markers of NO
bioavailability and/or muscle fiber type. Consistent with
the first hypothesis, we found a significant correlation
between the relative increase in Pmax and the relative
increase in plasma NO2
 concentration due to NO3

ingestion. Our second hypothesis, however, was not sup-
ported, as there was no association between the increase
in Pmax and baseline Vmax or fatigue index, in vivo indica-
tors of muscle fiber type distribution (see below). Finally,
our data provide preliminary support for the novel
hypothesis that, at least in terms of improvements in
maximal neuromuscular power, women are more likely
than men to benefit from dietary NO3
 supplementation.
Reduction in NO3
 to NO2
 by oral bacteria plays a
critical role in the production of NO via the enterosali-
vary pathway (Lundberg et al. 1994; Govoni et al. 2008;
Lundberg and Weitzberg 2009). In fact, this step appears
to be possibly rate-limiting, as demonstrated by the much
smaller increase in plasma NO2
 versus NO3
 following
NO3
 ingestion (Table 1). Accordingly, previous studies
have observed a significant correlation between the
magnitude of the increase in plasma NO2
 following
NO3
 ingestion and the improvement in endurance per-
formance ability (Wilkerson et al. 2012; Hoon et al.
2014). Our results are similar, as we found that interindi-
vidual differences in how much plasma NO2
 concentra-
tion was elevated by NO3
 intake accounted for about
one-third of the variation between individuals in the
increase in Pmax. It is possible that this significant corre-
lation reflects a direct effect of NO2
 on muscle contrac-
tility. Indeed, in cardiac muscle NO2
 has been shown to
nitrosylate cysteine residues of various membrane proteins
independently of NO (Montesanti et al. 2014). In skeletal
muscle, however, S-nitrosylation is thought to inhibit
contractile function; stimulatory effects are held to be the
result of NO-dependent soluble guanyl cyclase (sGC)/
–10
–5
0
5
10
15
20
25
30
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Δ%
 P
m
ax
Subject number
Average = +4.4% (P < 0.05)
Figure 1. Individual relative changes in maximal knee extensor
power (Pmax) in response to dietary NO3
 intake. Open bars, male
subjects. Closed bars, female subjects. The overall average response
is also shown (dashed line).
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Figure 2. Relationship of relative changes in maximal knee
extensor power (Pmax) to relative changes in plasma NO2

concentration in response to dietary NO3
 intake. Open symbols,
male subjects. Closed symbols, female subjects. Plasma samples
from one female subject were not available for analysis; data for
the remaining 19 subjects are therefore shown.
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cyclic GMP (cGMP)/protein kinase G (PKG) signaling
(Marechal and Gaily 1999). A direct effect of NO2

would therefore seemingly not explain the positive corre-
lation we observed between changes in plasma NO2
 and
changes in Pmax. Rather, this observation is consistent
with our first hypothesis that interindividual differences
in the availability of NO itself contribute to interindivid-
ual differences in the extent to which dietary NO3
 intake
increases muscle power.
Although we were able to at least partially confirm our
first hypothesis, our data do not support our second
hypothesis, which was that individuals with a greater per-
centage of fast-twitch fibers would demonstrate a greater
dietary NO3
-induced increase in muscle power. In par-
ticular, we found no correlation between the increase in
Pmax and Vmax or fatigue index during the placebo trial.
Although indirect, numerous previous studies have
demonstrated that these (or comparable) measurements
are significantly correlated with muscle fiber type (e.g.,
Coyle et al. 1979; Ivy et al. 1981; McCartney et al. 1983).
Moreover, Vmax and fatigue index were highly characteris-
tic of a given subject, as indicated their high intraclass
correlation coefficients. Given the strength of the associa-
tion between muscle fiber type, speed, and fatigability
found in previous studies (Coyle et al. 1979; Ivy et al.
1981; McCartney et al. 1983) along with the reproducibil-
ity of our measurements and the >2-fold range in Vmax
and fatigue index during the placebo trial, it seems unli-
kely that the lack of correlation of the latter measures
with the magnitude of the increase in Pmax with NO3

ingestion is the result a type II statistical error. On the
other hand, the premise that dietary NO3
 supplementa-
tion selectively targets fast-twitch fibers is based largely
on animal studies of muscle blood flow and oxygenation
during aerobic exercise, for example, (Ferguson et al.
2015), and is only indirectly supported by human data.
Specifically, Bailey et al. (2015) demonstrated dietary
NO3
-induced differences in muscle oxygenation, whole-
body VO2 kinetics, and performance during cycling when
pedaling at 115 rpm but not at 35 rpm. Breese et al.
(2013) reported similar benefits during the transition
from moderate to high-intensity exercise but not from
low to moderate intensity exercise. These data, along with
the fact that we have previously reported that NO3

improves muscle function only at higher velocities
(Coggan et al. 2015a,b), have been interpreted by Jones
et al. (2016) as reflecting enhanced recruitment of fast-
twitch fibers at a higher velocities/intensities of exercise.
It is unclear, however, whether altering pedaling rate in
fact changes the pattern of motor unit recruitment (Ahl-
quist et al. 1992). Similarly, the relationship between
exercise intensity and O2 flux is complex, with motor unit
recruitment being only one influencing factor (Jones et al.
2011). Finally, in both fast- and slow-twitch muscle NO
seems to improve contractile function by increasing the
rate of cross-bridge cycling, not the amount of force per
cross-bridge (Marechal and Gaily 1999). The resultant
shift in the force-velocity (and hence power-velocity)
curve, and not a selective impact only in fast-twitch
fibers, may therefore explain why we have previously
observed statistically significant NO3
-induced improve-
ments in power only at higher speeds of contraction
(Coggan et al. 2015a,b). The notion that dietary NO3

affects only, or even primarily, human fast-twitch fibers
would therefore still seem equivocal.
An unexpected observation in this study was that, at
least in terms of improvements in Pmax, women seem to
benefit more than men from dietary NO3
 intake. Specifi-
cally, although not significant in the univariable analyses,
female sex was the only predictor other than plasma
NO2
 concentration selected by the stepwise forward
regression procedure. Female subjects also tended to be
more to likely be “high responders” to NO3
 supplemen-
tation, with five out of seven demonstrating greater-than-
Table 2. Pearson-product correlation coefficients between D% Pmax and potential explanatory variables.
Sex Age Body mass BMI Placebo Vmax Placebo fatigue index D% NO3
 D% NO2

0.31 0.16 0.16 0.10 0.08 0.25 0.05 0.60*
*P < 0.01.
Table 3. Results of stepwise forward regression.
Predictor Beta coefficient SE Lower 95% CI Upper 95% CI t P
D% NO2
 0.038 0.014 0.011 0.064 2.81 0.005
Sex 0.056 0.032 0.006 0.118 1.76 0.079
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average increases in Pmax. This was true even though
NO3
 intake increased plasma NO2
 concentration simi-
larly in both women (i.e., +131  162%) and men (i.e.,
+124  93%). Previous studies of the effects of dietary
NO3
 on exercise performance have included only male
subjects (e.g., Christensen et al. 2013; Boorsma et al.
2014; Haider and Folland 2014; Hoon et al. 2014; Bailey
et al. 2015; Whitfield et al. 2017), or have not commented
on possible sex-related differences (e.g., Breese et al. 2013;
Hoon et al. 2015). It has been reported, however, that
plasma NO3
 (Jilma et al. 1996; Ghasemi et al. 2008)
and/or breath NO levels (Jilma et al. 1996; Olivieri et al.
2006) are lower in women. The reason for this difference
is not known, but it may be due to suppression of NO
production by progesterone (Scichilone et al. 2013) and/
or a sex-related difference in the distribution of a poly-
morphism in the neuronal NO synthase (NOS) gene
(Grasemann et al. 2003). Regardless, lower NO bioavail-
ability under baseline conditions could explain why the
women seemed to be more responsive to dietary NO3

intake. Indeed, we have previously observed an approxi-
mately twofold greater dietary NO3-induced improvement
in muscle power in patients with HF (Coggan et al.
2015a) compared to healthy control subjects (Coggan
et al. 2015b) or athletes (Rimer et al. 2016), presumably
because of diminished NOS-mediated NO production
(Katz et al. 1999) and enhanced NO destruction (M€unzel
et al. 2015) in patients with HF. Somewhat along the
same lines, Kapil et al. (2010) found that changes in
blood pressure in response to NO3
 ingestion were great-
est in individuals with lower baseline plasma NO2
 con-
centrations (and higher baseline blood pressures),
although in this case it was men who benefited the most.
In any case, future studies should more directly address
possible sex-related differences in the effects of NO3

ingestion on exercise performance.
There are a number of limitations to this study. The
most obvious is that muscle biopsies were not performed
to directly determine fiber type distribution, which poten-
tially could have revealed a relationship between the per-
centage of fast-twitch fibers and the relative increase in
Pmax. Our study also included a relatively small number
of individuals, only two of which were regular exercisers
and none of whom were presently competing in endur-
ance sports. Whether similar results would be obtained in
a larger group of subjects and/or among athletes therefore
cannot be determined from the present data. Although
we used a randomized, placebo-controlled, cross-over
design, there were no significant order effects, and Pmax,
Vmax, and fatigue index proved to be highly reliable, it is
possible that inclusion of a familiarization trial would
have altered the results (especially in the several subjects
in whom NO3
 ingestion seemed to impair muscle func-
tion.
Finally, although we have been able to identify two fac-
tors (i.e., plasma NO2
 concentration and possibly subject
sex) contributing to interindividual differences in the
effects of dietary NO3- on muscle contractile function, it
must be emphasized that over half of this variability
remains unexplained. Of course, some of this variability
represents normal day-to-day variation in human perfor-
mance (Coggan and Costill 1984), and is not due to NO3

ingestion per se. Such random variability, however, could
not explain the wide range of responses we observed, and
as indicated previously measurement of Pmax was highly
reproducible. Additional studies measuring NO3
 reduc-
tion in the mouth as well as NO/sGC/cGMP/PKG signaling
in muscle may provide further insight into the mechanism
(s) responsible for this marked interindividual variability
in the effects of dietary NO3
 on muscle power.
In summary, in this study we sought to identify factors
influencing the magnitude of the improvement in muscle
power due to dietary NO3
 intake. Our findings indicate
that variable increases in NO bioavailability, as indicated by
changes in plasma NO2
 concentration, along with subject
sex account for ~40% of this variability. On the other hand,
interindividual differences in muscle fiber type do not
appear to be important. Much of the variation in response
between individuals remains unexplained.
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